Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-04-03 4:46 pm Purchase | 2026-03-30 | 13G | ARTELO BIOSCIENCES INC ARTL | Mitchell P. Kopin | 81,701 9.990% | 81,701 (New Position) | Filing History |
| 2026-03-05 5:20 pm Purchase | 2026-02-27 | 13G | AVALON GLOBOCARE CORP COM PAR ALBT | Mitchell P. Kopin | 490,197 7.000% | 490,197 (New Position) | Filing History |
| 2026-02-20 4:15 pm Purchase | 2026-02-17 | 13G | LIMINATUS PHARMA INC LIMN | Mitchell P. Kopin | 2,065,885 4.990% | 2,065,885 (New Position) | Filing History |
| 2026-02-18 4:12 pm Purchase | 2026-02-11 | 13G | BIORESTORATIVE THERAPIES INC.C BRTX | Mitchell P. Kopin | 922,143 4.100% | 922,143 (New Position) | Filing History |
| 2026-02-17 4:09 pm Purchase | 2026-02-11 | 13G | MDJM LTD USD UOKA | Mitchell P. Kopin | 627 9.990% | 627 (New Position) | Filing History |
| 2026-02-13 4:49 pm Purchase | 2025-12-31 | 13G | SILEXION THERAPEUTICS CORP SLXN | Mitchell P. Kopin | 325,000 9.400% | 80,229 (+32.78%) | Filing History |
| 2026-02-13 4:48 pm Purchase | 2025-12-31 | 13G | SILO PHARMA INC SILO | Mitchell P. Kopin | 1,478,164 9.990% | 93,754 (+6.77%) | Filing History |
| 2026-02-13 4:47 pm Sale | 2025-12-31 | 13G | PHARMACYTE BIOTECH INC PMCB | Mitchell P. Kopin | 532,254 4.990% | -163,461 (-23.50%) | Filing History |
| 2026-02-13 4:46 pm Purchase | 2025-12-31 | 13G | PHIO PHARMACEUTICALS CORP COM PHIO | Mitchell P. Kopin | 1,142,556 9.100% | 712,556 (+165.71%) | Filing History |
| 2026-02-13 4:45 pm Purchase | 2025-12-31 | 13G | PROCESSA PHARMACEUTICALS INC PCSA | Mitchell P. Kopin | 200,000 8.100% | 83,710 (+71.98%) | Filing History |
| 2026-02-13 4:44 pm Purchase | 2025-12-31 | 13G | INNOVATIVE EYEWEAR INC LUCY | Mitchell P. Kopin | 593,804 9.990% | 86,080 (+16.95%) | Filing History |
| 2026-02-13 4:43 pm Purchase | 2025-12-31 | 13G | SEASTAR MED HLDG CORP COM ICU | Mitchell P. Kopin | 3,980,665 9.990% | 3,670,847 (+1184.84%) | Filing History |
| 2026-02-13 4:43 pm Purchase | 2025-12-31 | 13G | GRI BIO INC PAR $0.0001 NE GRI | Mitchell P. Kopin | 1,097,858 9.990% | 1,073,662 (+4437.35%) | Filing History |
| 2026-02-13 4:41 pm Purchase | 2025-12-31 | 13G | GEOVAX LABS INC PAR $0.001 GOVX | Mitchell P. Kopin | 4,806,174 9.990% | 4,692,200 (+4116.90%) | Filing History |
| 2026-02-13 4:39 pm Purchase | 2025-12-31 | 13G | CEMTREX INC PAR $.001 CETX | Mitchell P. Kopin | 605,011 7.300% | 522,993 (+637.66%) | Filing History |
| 2026-02-13 4:38 pm Purchase | 2025-12-31 | 13G | BLUEJAY DIAGNOSTICS INC PA BJDX | Mitchell P. Kopin | 91,537 4.990% | 47,142 (+106.19%) | Filing History |
| 2026-02-13 4:37 pm Purchase | 2025-12-31 | 13G | ASCENT SOLAR TECHNOLOGIES INC ASTI | Mitchell P. Kopin | 475,116 9.990% | 136,864 (+40.46%) | Filing History |
| 2026-02-13 4:36 pm Purchase | 2025-12-31 | 13G | ACTELIS NETWORKS INC ASNS | Mitchell P. Kopin | 849,800 9.990% | 655,817 (+338.08%) | Filing History |
| 2026-02-13 4:30 pm Purchase | 2026-02-09 | 13G | IVEDA SOLUTIONS INC PAR $. IVDA | Mitchell P. Kopin | 592,195 4.990% | 592,195 (New Position) | Filing History |
| 2026-02-04 4:21 pm Purchase | 2026-01-29 | 13G | TIAN RUIXIANG HLDGS LTD CLASS TIRXF | Mitchell P. Kopin | 10,100,615 9.990% | 10,089,882 (+94008.03%) | Filing History |